
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen
Xiaoling Xie, Yuxing Hu, Tong Ye, et al.
Nature Biomedical Engineering (2020) Vol. 5, Iss. 5, pp. 414-428
Closed Access | Times Cited: 73
Xiaoling Xie, Yuxing Hu, Tong Ye, et al.
Nature Biomedical Engineering (2020) Vol. 5, Iss. 5, pp. 414-428
Closed Access | Times Cited: 73
Showing 1-25 of 73 citing articles:
Vaccine adjuvants: mechanisms and platforms
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 316
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 316
Bioinspired and Biomimetic Delivery Platforms for Cancer Vaccines
Jing Liu, Si Si Liew, Jun Wang, et al.
Advanced Materials (2021) Vol. 34, Iss. 1
Closed Access | Times Cited: 124
Jing Liu, Si Si Liew, Jun Wang, et al.
Advanced Materials (2021) Vol. 34, Iss. 1
Closed Access | Times Cited: 124
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 82
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 82
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 630-638
Closed Access | Times Cited: 54
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 630-638
Closed Access | Times Cited: 54
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
Jing Liu, Horacio Cabral, Peng Mi
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115239-115239
Closed Access | Times Cited: 51
Jing Liu, Horacio Cabral, Peng Mi
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115239-115239
Closed Access | Times Cited: 51
Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
Liu Guang-na, Motao Zhu, Xiao Zhao, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113889-113889
Closed Access | Times Cited: 78
Liu Guang-na, Motao Zhu, Xiao Zhao, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113889-113889
Closed Access | Times Cited: 78
The Development of Chiral Nanoparticles to Target NK Cells and CD8+ T Cells for Cancer Immunotherapy
Weiwei Wang, Jing Zhao, Changlong Hao, et al.
Advanced Materials (2022) Vol. 34, Iss. 16
Closed Access | Times Cited: 68
Weiwei Wang, Jing Zhao, Changlong Hao, et al.
Advanced Materials (2022) Vol. 34, Iss. 16
Closed Access | Times Cited: 68
Sustained delivery approaches to improving adaptive immune responses
Ben S. Ou, Olivia M. Saouaf, Julie Baillet, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114401-114401
Open Access | Times Cited: 62
Ben S. Ou, Olivia M. Saouaf, Julie Baillet, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114401-114401
Open Access | Times Cited: 62
Antibody-based drug delivery systems for cancer therapy: Mechanisms, challenges, and prospects
Zhoujiang Chen, Ranjith Kumar Kankala, Zhiyong Yang, et al.
Theranostics (2022) Vol. 12, Iss. 8, pp. 3719-3746
Open Access | Times Cited: 53
Zhoujiang Chen, Ranjith Kumar Kankala, Zhiyong Yang, et al.
Theranostics (2022) Vol. 12, Iss. 8, pp. 3719-3746
Open Access | Times Cited: 53
Polymeric nanoparticle-based nanovaccines for cancer immunotherapy
Yongxin Zhang, Jiajing Chen, Linqi Shi, et al.
Materials Horizons (2022) Vol. 10, Iss. 2, pp. 361-392
Closed Access | Times Cited: 51
Yongxin Zhang, Jiajing Chen, Linqi Shi, et al.
Materials Horizons (2022) Vol. 10, Iss. 2, pp. 361-392
Closed Access | Times Cited: 51
Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
Shaobo Ruan, Yuanyu Huang, Mei He, et al.
Advanced Science (2022) Vol. 9, Iss. 16
Open Access | Times Cited: 43
Shaobo Ruan, Yuanyu Huang, Mei He, et al.
Advanced Science (2022) Vol. 9, Iss. 16
Open Access | Times Cited: 43
Exosome-loaded degradable polymeric microcapsules for the treatment of vitreoretinal diseases
Han Bao, Ying Tian, Haixin Wang, et al.
Nature Biomedical Engineering (2023) Vol. 8, Iss. 11, pp. 1436-1452
Closed Access | Times Cited: 33
Han Bao, Ying Tian, Haixin Wang, et al.
Nature Biomedical Engineering (2023) Vol. 8, Iss. 11, pp. 1436-1452
Closed Access | Times Cited: 33
Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies
Yingying Hou, Min Chen, Yuan Bian, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3321-3338
Open Access | Times Cited: 29
Yingying Hou, Min Chen, Yuan Bian, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3321-3338
Open Access | Times Cited: 29
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Jinxin Li, Qiwei Wang, Yingli Han, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 26
Jinxin Li, Qiwei Wang, Yingli Han, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 26
Long-acting vaccine delivery systems
Pavan Walvekar, Pradeep Kumar, Yahya E. Choonara
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114897-114897
Closed Access | Times Cited: 22
Pavan Walvekar, Pradeep Kumar, Yahya E. Choonara
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114897-114897
Closed Access | Times Cited: 22
Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic photothermal immunotherapy
Ke‐Fei Xu, Shun‐Yu Wu, Zihao Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Ke‐Fei Xu, Shun‐Yu Wu, Zihao Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery
Jinxin Li, Honghui Wu, Zebin Yu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Jinxin Li, Honghui Wu, Zebin Yu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Toward Clinical Applications: Transforming Nonantibiotic Antibacterials into Effective Next-Generation Supramolecular Therapeutics
Christian K. O. Dzuvor
ACS Nano (2024) Vol. 18, Iss. 4, pp. 2564-2577
Closed Access | Times Cited: 9
Christian K. O. Dzuvor
ACS Nano (2024) Vol. 18, Iss. 4, pp. 2564-2577
Closed Access | Times Cited: 9
NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses
Lirong Zhang, Jingjing Zhang, Lixia Xu, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 42
Lirong Zhang, Jingjing Zhang, Lixia Xu, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 42
Delivery strategies in treatments of leukemia
Tianyuan Ci, Wentao Zhang, Yingyu Qiao, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 6, pp. 2121-2144
Closed Access | Times Cited: 29
Tianyuan Ci, Wentao Zhang, Yingyu Qiao, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 6, pp. 2121-2144
Closed Access | Times Cited: 29
Bioresponsive Immunotherapeutic Materials
Jinpeng Han, Tao Sheng, Yuqi Zhang, et al.
Advanced Materials (2023) Vol. 36, Iss. 43
Closed Access | Times Cited: 21
Jinpeng Han, Tao Sheng, Yuqi Zhang, et al.
Advanced Materials (2023) Vol. 36, Iss. 43
Closed Access | Times Cited: 21
Toxicities of polystyrene microplastics (MPs) and hexabromocyclododecane (HBCD), alone or in combination, to the hepatopancreas of the whiteleg shrimp, Litopenaeus vannamei
Yihan Yu, Lihua Hu, Dandan Tian, et al.
Environmental Pollution (2023) Vol. 329, pp. 121646-121646
Closed Access | Times Cited: 20
Yihan Yu, Lihua Hu, Dandan Tian, et al.
Environmental Pollution (2023) Vol. 329, pp. 121646-121646
Closed Access | Times Cited: 20
Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care
Yao Xiao, Zi‐Zhan Li, Nian‐Nian Zhong, et al.
Translational Oncology (2023) Vol. 38, pp. 101794-101794
Open Access | Times Cited: 16
Yao Xiao, Zi‐Zhan Li, Nian‐Nian Zhong, et al.
Translational Oncology (2023) Vol. 38, pp. 101794-101794
Open Access | Times Cited: 16
Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development
Jie Liang, Xiao Zhao
Cancer Biology and Medicine (2021) Vol. 18, Iss. 2, pp. 352-371
Open Access | Times Cited: 36
Jie Liang, Xiao Zhao
Cancer Biology and Medicine (2021) Vol. 18, Iss. 2, pp. 352-371
Open Access | Times Cited: 36
Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia
Hao Wang, Yingqi Qiu, H Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 15
Hao Wang, Yingqi Qiu, H Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 15